Literature DB >> 31654570

Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.

Ting Xie1, Wing Yan So1, Xing Yu Li1, Po Sing Leung1.   

Abstract

Fibroblast growth factor 21 (FGF21) is known as a potent metabolic regulator but its protective mechanisms against lipotoxicity-induced β-cell dysfunction and apoptosis remain elusive. Here, we aimed to examine the regulatory pathways whereby FGF21 mediates islet lipid metabolism in lipotoxicity-treated cells and animal models. Rat β-cell line (INS-1E cells) and islets isolated from C57/BL6J mice were exposed to palmitic acid (PA) with/without FGF21, mimicking lipotoxic conditions. Resultant insulin secretion and intracellular signaling were analyzed with Western blotting and RNA-seq. C57/BL6J and global FGF21 knockout (KO) mice were fed with a high-fat diet (HFD) to induce lipotoxicity and given with a long-acting mimetic of FGF21. Insulin resistance and β-cell function were then assessed using homeostasis model assessment of insulin resistance (HOMA-IR) and insulinogenic index. FGF21 ameliorated PA-induced lipid accumulation, reversed cell apoptosis, and enhanced glucose-stimulated insulin secretion (GSIS) as impaired by lipotoxicity in islet β-cells. Mechanistically, FGF21 exerted its beneficial effects through activation of AMPK-ACC (acetyl-CoA carboxylase) pathway and peroxisome proliferation-activated receptors (PPARs) δ/γ signaling, thus increasing the levels of carnitine palmitoyltransferase-1A (CPT1A) and leading to increased fatty acid (FA) oxidation and reduced lipid deposition in β-cells. Interestingly, FGF21 reduced PA-induced cell death via restoration of the expression of apoptosis inhibitor Birc3. In vivo studies further showed that FGF21 is critical for islet insulinogenic capacity and normal function in the context of HFD-treated animals. FGF21 down-regulates islet cell lipid accumulation, probably via activation of AMPK-ACC and PPARδ/γ signaling, and reduces cell death under lipotoxicity, indicating that FGF21 is protective against lipotoxicity-induced β-cell dysfunction and apoptosis.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Apoptosis; CVX343; Insulin; Islets; Obesity; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31654570     DOI: 10.1042/CS20190093

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  15 in total

Review 1.  FGF21 in obesity and cancer: New insights.

Authors:  Weiqin Lu; Xiaokun Li; Yongde Luo
Journal:  Cancer Lett       Date:  2020-11-29       Impact factor: 8.679

2.  Platelet biomarkers for a descending cognitive function: A proteomic approach.

Authors:  Haitao Yu; Yanchao Liu; Benrong He; Ting He; Chongyang Chen; Jiahua He; Xifei Yang; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2021-05-04       Impact factor: 9.304

3.  FGF21 Serum Levels in the Early Second Trimester Are Positively Correlated With the Risk of Subsequent Gestational Diabetes Mellitus: A Propensity-Matched Nested Case-Control Study.

Authors:  Zhiheng Wang; Min Yuan; Chengjie Xu; Yang Zhang; Chunmei Ying; Xirong Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

Review 4.  Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity.

Authors:  Yongde Luo; Xiaokun Li; Jianjia Ma; James L Abbruzzese; Weiqin Lu
Journal:  Cancers (Basel)       Date:  2021-02-13       Impact factor: 6.639

Review 5.  FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.

Authors:  Erik J Tillman; Tim Rolph
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-14       Impact factor: 5.555

6.  Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model.

Authors:  Hyo Jin Maeng; Gha Young Lee; Jae Hyun Bae; Soo Lim
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

7.  Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes.

Authors:  Xiaoli Liu; Lanxiang Liu; Rui Wang; Xiaojiao Jia; Binbin Liu; Ning Ma; Qiang Lu
Journal:  Endocr Connect       Date:  2021-06-11       Impact factor: 3.335

8.  RNF6 Targeted by miR-26a-5p Protects Pancreatic β-Cell Function Against Type 2 Diabetes.

Authors:  Fan Yang; Shengxun Zhao; Xuyan Zhang; Sheng Ding; Yancheng Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-11       Impact factor: 3.168

Review 9.  Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical Options.

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Healthcare (Basel)       Date:  2021-12-21

10.  JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation.

Authors:  Kexin Wang; Yixin Cui; Peng Lin; Zhina Yao; Yu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.